New Japan Chemical Co., Ltd. (TYO:4406)
Japan · Delayed Price · Currency is JPY 234.00
-2.00 (-0.85%)
At close: Feb 6, 2026
New Japan Chemical Income Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
| 32,392 | 32,703 | 32,863 | 33,105 | 32,358 | 24,437 | |
Revenue Growth (YoY) | -2.77% | -0.49% | -0.73% | 2.31% | 32.41% | -8.95% |
Cost of Revenue | 26,802 | 27,249 | 27,547 | 28,687 | 26,473 | 19,879 |
Gross Profit | 5,590 | 5,454 | 5,316 | 4,418 | 5,885 | 4,558 |
Selling, General & Admin | 3,760 | 3,678 | 4,106 | 3,979 | 3,858 | 4,269 |
Research & Development | 946 | 946 | 848 | 878 | 824 | - |
Operating Expenses | 4,706 | 4,624 | 4,954 | 4,857 | 4,682 | 4,269 |
Operating Income | 884 | 830 | 362 | -439 | 1,203 | 289 |
Interest Expense | -54 | -50 | -47 | -51 | -44 | -42 |
Interest & Investment Income | 185 | 175 | 177 | 170 | 147 | 138 |
Earnings From Equity Investments | 129 | 392 | 228 | 401 | 179 | 244 |
Currency Exchange Gain (Loss) | -18 | -26 | -2 | -21 | - | 1 |
Other Non Operating Income (Expenses) | -104 | -109 | 66 | 62 | 103 | 74 |
EBT Excluding Unusual Items | 1,022 | 1,212 | 784 | 122 | 1,588 | 704 |
Gain (Loss) on Sale of Investments | 363 | 271 | 221 | -3 | -132 | 162 |
Gain (Loss) on Sale of Assets | -16 | -16 | -5 | -17 | - | - |
Asset Writedown | - | - | -253 | -332 | -526 | -187 |
Other Unusual Items | -744 | -744 | -229 | -1 | -1 | - |
Pretax Income | 625 | 723 | 518 | -231 | 929 | 679 |
Income Tax Expense | 114 | 155 | 182 | 166 | 49 | 126 |
Earnings From Continuing Operations | 511 | 568 | 336 | -397 | 880 | 553 |
Minority Interest in Earnings | -43 | -46 | -116 | -47 | -69 | -52 |
Net Income | 468 | 522 | 220 | -444 | 811 | 501 |
Net Income to Common | 468 | 522 | 220 | -444 | 811 | 501 |
Net Income Growth | -25.24% | 137.27% | - | - | 61.88% | 8.91% |
Shares Outstanding (Basic) | 37 | 37 | 37 | 37 | 37 | 37 |
Shares Outstanding (Diluted) | 37 | 37 | 37 | 37 | 37 | 37 |
Shares Change (YoY) | -0.00% | -0.00% | -0.00% | - | -0.00% | -0.00% |
EPS (Basic) | 12.55 | 14.00 | 5.90 | -11.91 | 21.75 | 13.44 |
EPS (Diluted) | 12.55 | 14.00 | 5.90 | -11.91 | 21.75 | 13.44 |
EPS Growth | -25.24% | 137.28% | - | - | 61.88% | 8.92% |
Free Cash Flow | 1,231 | -889 | 2,799 | -589 | -705 | -679 |
Free Cash Flow Per Share | 33.02 | -23.84 | 75.07 | -15.80 | -18.91 | -18.21 |
Dividend Per Share | 4.000 | 4.000 | - | - | 5.000 | 3.000 |
Dividend Growth | - | - | - | - | 66.67% | - |
Gross Margin | 17.26% | 16.68% | 16.18% | 13.35% | 18.19% | 18.65% |
Operating Margin | 2.73% | 2.54% | 1.10% | -1.33% | 3.72% | 1.18% |
Profit Margin | 1.44% | 1.60% | 0.67% | -1.34% | 2.51% | 2.05% |
Free Cash Flow Margin | 3.80% | -2.72% | 8.52% | -1.78% | -2.18% | -2.78% |
EBITDA | 1,673 | 1,618 | 1,104 | 271 | 1,969 | 920 |
EBITDA Margin | 5.17% | 4.95% | 3.36% | 0.82% | 6.08% | 3.77% |
D&A For EBITDA | 789 | 788 | 742 | 710 | 766 | 631 |
EBIT | 884 | 830 | 362 | -439 | 1,203 | 289 |
EBIT Margin | 2.73% | 2.54% | 1.10% | -1.33% | 3.72% | 1.18% |
Effective Tax Rate | 18.24% | 21.44% | 35.13% | - | 5.27% | 18.56% |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.